Trial site
Cincinnati Childrens Hospital Medical Center
- 8running trials
- 12closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers5 trials
- Acute lymphoblastic leukaemia2 trials
- Autism2 trials
- Depression2 trials
- Alopecia areata1 trial
- Asthma1 trial
- Atopic dermatitis (eczema)1 trial
- Chronic kidney disease1 trial
- Down syndrome1 trial
- Duchenne muscular dystrophy1 trial
- Glioblastoma1 trial
- Haemophilia1 trial
- and 11 more
- Phase
- Phase 36 trials
- Phase 13 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Completed10 trials
- Active, not recruiting4 trials
- Recruiting3 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati6 trials
- Amgen3 trials
- Eli Lilly and Company3 trials
- Incyte Corporation2 trials
- Duke University1 trial
- and 5 more
Running trials
Recruiting
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
Recruiting
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
Active, not recruiting
Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alopecia areata1 recruiting
- Childhood cancers1 recruiting
- Depression1 recruiting
- Neurofibromatosis type 11 recruiting
Closed trials
Completed
Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder
Completed
Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD)
Terminated
Completed
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Completed
A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes
Recruiting
Completed
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
Recruiting
Completed
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus
Completed
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026